MedTrace Logo

Evaluation of OSSIX-Plus Resorbable Collagen Membranes for Alveolar Ridge Preservation Following Exodontia

NCT00639860 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2016-03-31

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate clinically, histologically and radiographically the healing of extraction sockets covered with a resorbable collagen membrane (OSSIX-Plus) 12 weeks following exodontia.

Conditions

  • Alveolar Bone Loss
  • Loss of Teeth Due to Extraction
  • Edentulous Alveolar Ridge

Interventions

DEVICE

OSSIX-Plus

resorbable collagen membrane

Sponsors & Collaborators

  • Johnson & Johnson

    collaborator INDUSTRY

  • OraPharma

    collaborator INDUSTRY

  • William Giannobile

    lead OTHER

Principal Investigators

  • William V Giannobile, DDS, DMedSc · Professor

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2009-03-31
Completion
2009-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00639860 on ClinicalTrials.gov